You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

May 28, 2012

PLC Life Sciences Multi-Jurisdictional Guide 2012 – Vietnam Chapter

Practical Law Company

With the tightening of budgets and increased scrutiny by the Ministry of Health, this article delves into the practicability of Vietnam’s regulatory framework governing the life sciences industry. Ranging from the quality of national healthcare, manufacturing authorization, marketing, and pricing of medicinal products, to the intellectual property surrounding each product and the scope of product liability law in this industry, this Q&A chapter provides a detailed overview of the effect of key legislation and the power of regulatory authorities. In particular, the chapter covers:

  • Pricing Structure: Costs and state funding of medicinal products and national healthcare
  • Manufacturing: Authorization, conditions, fees, and validity of licenses
  • Marketing: Fees, conditions, authorization, packaging requirements, foreign marketing authorizations, parallel imports, and restrictions such as marketing on the internet
  • Traditional Medicine: Manufacturing and marketing regulations
  • Patent Law: Conditions, patentable products, scope of protection, validity, revocation, infringement, and remedies available
  • Trademark Law: Conditions, scope of protection, duration of protection, revocation, infringement, remedies available, and relevant international conventions
  • Product Liability Law: Key legislation, the substantive test, procedures of bringing a claim, defenses and remedies available, limitation periods, and parties liable under the Consumer Protection Law
  • Proposals for Reform: The Draft Law on Advertisement, and further guidance through implementing circulars

This chapter was published by Practical Law Company, a leading provider of legal guidance, analysis, and market intelligence in up to 30 jurisdictions.

RELATED INSIGHTS​ 

March 19, 2020
The effects of the global COVID-19 pandemic on Southeast Asia are a deep concern shared by all with connections to the region. To encourage clear understanding of the facts on the ground, Tilleke & Gibbins has prepared this high-level snapshot of the legal situation as it currently stands in each of our jurisdictions.Administrative and Judicial Functions
March 18, 2020
On February 24, 2020, the government of Vietnam issued Decree No. 24/2020/ND-CP (“Decree 24”) providing detailed guidance on the 2019 Law on Prevention and Control of Harmful Effects of Alcoholic Beverages (the “Law on Alcoholic Beverages”), which took effect on January 1, 2020. Among other things, Decree 24 provides further guidance about the restrictions on consumption, advertising, and trading of alcoholic beverages. Below is a summary of these provisions:Consumption of alcoholic beverages
March 2, 2020
Non-communicable diseases (NCDs) mainly consist of cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes, and are the most frequent causes of death worldwide. A 2018 World Health Organization (WHO) fact sheet on NCDs notes that 41 million people die annually from NCDs (71% of global deaths), including 15 million people who die before the age of 70.